Novo Nordisk A/S
Copenhagen : NOVO B

August 08, 2013 02:07 ET

Novo Nordisk A/S: Novo Nordisk increased operating profit by 15% in the first six months of 2013

BAGSVAERD, DENMARK--(Marketwired - Aug 8, 2013) - Sales increased by 14% in local currencies and by 11% in Danish kroner to DKK 41.4 billion.

- Sales of modern insulins increased by 15% (13% in Danish kroner).

- Sales of Victoza® increased by 32% (30% in Danish kroner).

- Sales in North America increased by 23% (21% in Danish kroner).

- Sales in International Operations increased by 17% (12% in Danish kroner).

Company announcemen No 54 / 2013:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE


Contact Information